Philip Leder
25Patents
11h-index
22Co-inventors
75Inventor score
Filing activity: Feb 25, 1983 → Apr 3, 2003
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4736866A | Transgenic non-human mammals | Chemistry; Metallurgy | 524 | Expired |
| US5175383A | Animal model for benign prostatic disease | Human Necessities | 115 | Expired |
| US5474981A | Use of the cytokine IP-10 as an anti-tumor agent | Human Necessities | 90 | Expired |
| US6403782B1 | Nucleic acid encoding eotaxin | Human Necessities | 34 | Expired |
| US4962035A | DNA encoding IgE receptor alpha-subunit or fragment thereof | Human Necessities | 31 | Expired |
| US5087571A | Method for providing a cell culture from a transgenic non-human mammal | Chemistry; Metallurgy | 30 | Expired |
| US5824299A | Modulation of endothelial cell proliferation with IP-10 | Chemistry; Metallurgy | 29 | Expired |
| US5789182A | System for assaying binding to a heparin-binding growth factor receptor | Physics | 21 | Expired |
| US5674734A | Cell death protein | Human Necessities | 19 | Expired |
| US6780973B1 | Eotaxin: an eosinophil chemoattractant | Human Necessities | 18 | Expired |
| US4599308A | Protein from SV40 recombinants | Chemistry; Metallurgy | 17 | Expired |
| US5925803A | Testing method using transgenic mice expressing an oncogene | Chemistry; Metallurgy | 8 | Expired |
| US5270197A | Cells expressing a substantial number of surface high affinity HBGF receptors but relatively few low affinity HBGF binding sites and system for assaying binding to HBGF receptor | Physics | 7 | Expired |
| US5459058A | Cell culture system | Chemistry; Metallurgy | 7 | Expired |
| US4542096A | Detecting rearranged human c-myc DNA fragments associated with oncogenes | Chemistry; Metallurgy | 6 | Expired |
| US6504081B1 | Methods and uses for transposon-based gene targeting | Human Necessities | 2 | Expired |
| US5728579A | DNA encoding Mat-8 | Human Necessities | 2 | Expired |
| US5935567A | Cytokine IP-10 as an anti-tumor agent | Human Necessities | 2 | Expired |
| US6153600A | Use of the cytokine IP-10 as an anti-tumor agent | Human Necessities | 2 | Expired |
| US7348156B2 | 7B2 knockout transgenic animals as models of endocrine disease | Human Necessities | 1 | Expired |
| US6548736B1 | 7B2 knockout transgenic animals as models of endocrine disease | Human Necessities | 0 | Expired |
| US7202333B1 | DNA encoding IgE Receptor α-subunit or fragment thereof | Human Necessities | 0 | Expired |
| US5554499A | Detection and isolation of ligands | Emerging Cross-Sectional Technologies | 0 | Expired |
| US5759856A | Cell culture system | Chemistry; Metallurgy | 0 | Expired |
| US5801000A | Detection and isolation of receptors | Emerging Cross-Sectional Technologies | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.